Nevro Corp. (NYSE:NVRO) stock dipped -3.28% and closed at $79.65 in last trading session. The stock opened the session at $82.43 and touched its highest price point at $84. Its recent trading capacity is 340376 shares versus to its average trading volume of 360047 shares. The company’s stock’s lowest price point for the session stood at $78.98.NVRO traded as low as $ 65 in the past 52 weeks, and shares hit its peak level to $99.63.
Nevro Corp. (NYSE:NVRO) recently announced financial results for the three months and full year ended December 31, 2017.
Fourth Quarter Financial Results
Revenue for the quarter ended December 31, 2017 was $98.0 million versus $70.5 million during the same period of the prior year, representing 39% growth as reported. U.S. revenue for the three months ended December 31, 2017 was $81.1 million, representing 45% growth as reported. International revenue was $16.9 million, representing growth of 10% in constant currency and 17% on an as-reported basis. The increase in revenue was primarily attributable to the continued adoption of the Senza system.
Gross profit for the fourth quarter of 2017 was $69.5 million, representing a 71% gross margin, up from $48.8 million, representing a 69% gross margin, in the same period of the prior year.
Operating expenses for the fourth quarter of 2017 were $71.7 million compared to $55.1 million in the same period of the prior year, representing an increase of 30%. The increase in operating expenses was driven primarily by increased headcount and related personnel costs, as well as legal expenses associated with intellectual property litigations.
Loss from operations for the fourth quarter of 2017 was $2.2 million compared to $6.3 million for the same period of the prior year.
Revenue Guidance for Full Year 2018
Nevro reiterates worldwide revenue for 2018 to be in the range of $400.0 to $410.0 million, which was first announced in January 2018.